Skip to main content
. 2019 Oct 7;20(19):4943. doi: 10.3390/ijms20194943
BC breast cancer
CDK cyclin-dependent kinase
CDKN2A cyclin-dependent kinase inhibitor 2A
DSB double-strand break
ER estrogen receptor
FITC fluorescein isothiocyanate
HER2 human epidermal growth factor receptor 2
NSCLC non-small cell lung cancer
PARP poly (ADP-ribose) polymerase
PR progesterone receptor
RB retinoblastoma susceptibility gene
RBE relative biological effectiveness
RIPA radio-immunoprecipitation assay
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SF survival fraction
siRNA small interfering ribonucleic acid
SOBP spread-out Bragg peak
TNBC triple-negative breast cancer